TY - JOUR
T1 - The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
AU - on behalf of the SepsisDataNet.NRW research group
AU - Unterberg, Matthias
AU - Rahmel, Tim
AU - Rump, Katharina
AU - Wolf, Alexander
AU - Haberl, Helge
AU - von Busch, Alexander
AU - Bergmann, Lars
AU - Bracht, Thilo
AU - Zarbock, Alexander
AU - Ehrentraut, Stefan Felix
AU - Putensen, Christian
AU - Wappler, Frank
AU - Köhler, Thomas
AU - Ellger, Björn
AU - Babel, Nina
AU - Frey, Ulrich
AU - Eisenacher, Martin
AU - Kleefisch, Daniel
AU - Marcus, Katrin
AU - Sitek, Barbara
AU - Adamzik, Michael
AU - Koos, Björn
AU - Nowak, Hartmuth
AU - Anft, Moritz
AU - Annecke, Thorsten
AU - Bazzi, Maha
AU - Bode, Christian
AU - Defosse, Jerome M.
AU - Ehrentraut, Stefan F.
AU - Eisennacher, Martin
AU - Ertmer, Christian
AU - Frey, Ulrich H.
AU - Fuchs, Katrin
AU - Henzler, Dietrich
AU - Koos, Björn
AU - Limper, Ulrich
AU - Oswald, Daniel
AU - Schewe, Jens Christian
AU - Schwier, Elke
AU - Willemsen, Katrin
AU - Zuelch, Birgit
N1 - Funding Information:
Open Access funding enabled and organized by Projekt DEAL. ME is part of the Center for Protein Diagnostics (PROD), funded by the Ministry of Innovation, Science and Research of North-Rhine Westphalia, Germany. The SepsisDataNet.NRW study was supported by the European Regional Development Fund (ERDF). We acknowledge support by the Open Access Publication Funds of the Ruhr-Universität Bochum.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: The COVID-19 pandemic has taken a toll on health care systems worldwide, which has led to increased mortality of different diseases like myocardial infarction. This is most likely due to three factors. First, an increased workload per nurse ratio, a factor associated with mortality. Second, patients presenting with COVID-19-like symptoms are isolated, which also decreases survival in cases of emergency. And third, patients hesitate to see a doctor or present themselves at a hospital. To assess if this is also true for sepsis patients, we asked whether non-COVID-19 sepsis patients had an increased 30-day mortality during the COVID-19 pandemic. Methods: This is a post hoc analysis of the SepsisDataNet.NRW study, a multicentric, prospective study that includes septic patients fulfilling the SEPSIS-3 criteria. Within this study, we compared the 30-day mortality and disease severity of patients recruited pre-pandemic (recruited from March 2018 until February 2020) with non-COVID-19 septic patients recruited during the pandemic (recruited from March 2020 till December 2020). Results: Comparing septic patients recruited before the pandemic to those recruited during the pandemic, we found an increased raw 30-day mortality in sepsis-patients recruited during the pandemic (33% vs. 52%, p = 0.004). We also found a significant difference in the severity of disease at recruitment (SOFA score pre-pandemic: 8 (5 - 11) vs. pandemic: 10 (8 - 13); p < 0.001). When adjusted for this, the 30-day mortality rates were not significantly different between the two groups (52% vs. 52% pre-pandemic and pandemic, p = 0.798). Conclusions: This led us to believe that the higher mortality of non-COVID19 sepsis patients during the pandemic might be attributed to a more severe septic disease at the time of recruitment. We note that patients may experience a delayed admission, as indicated by elevated SOFA scores. This could explain the higher mortality during the pandemic and we found no evidence for a diminished quality of care for critically ill sepsis patients in German intensive care units.
AB - Background: The COVID-19 pandemic has taken a toll on health care systems worldwide, which has led to increased mortality of different diseases like myocardial infarction. This is most likely due to three factors. First, an increased workload per nurse ratio, a factor associated with mortality. Second, patients presenting with COVID-19-like symptoms are isolated, which also decreases survival in cases of emergency. And third, patients hesitate to see a doctor or present themselves at a hospital. To assess if this is also true for sepsis patients, we asked whether non-COVID-19 sepsis patients had an increased 30-day mortality during the COVID-19 pandemic. Methods: This is a post hoc analysis of the SepsisDataNet.NRW study, a multicentric, prospective study that includes septic patients fulfilling the SEPSIS-3 criteria. Within this study, we compared the 30-day mortality and disease severity of patients recruited pre-pandemic (recruited from March 2018 until February 2020) with non-COVID-19 septic patients recruited during the pandemic (recruited from March 2020 till December 2020). Results: Comparing septic patients recruited before the pandemic to those recruited during the pandemic, we found an increased raw 30-day mortality in sepsis-patients recruited during the pandemic (33% vs. 52%, p = 0.004). We also found a significant difference in the severity of disease at recruitment (SOFA score pre-pandemic: 8 (5 - 11) vs. pandemic: 10 (8 - 13); p < 0.001). When adjusted for this, the 30-day mortality rates were not significantly different between the two groups (52% vs. 52% pre-pandemic and pandemic, p = 0.798). Conclusions: This led us to believe that the higher mortality of non-COVID19 sepsis patients during the pandemic might be attributed to a more severe septic disease at the time of recruitment. We note that patients may experience a delayed admission, as indicated by elevated SOFA scores. This could explain the higher mortality during the pandemic and we found no evidence for a diminished quality of care for critically ill sepsis patients in German intensive care units.
UR - http://www.scopus.com/inward/record.url?scp=85122304018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122304018&partnerID=8YFLogxK
U2 - 10.1186/s12871-021-01547-8
DO - 10.1186/s12871-021-01547-8
M3 - Article
C2 - 34986787
AN - SCOPUS:85122304018
SN - 1471-2253
VL - 22
JO - BMC Anesthesiology
JF - BMC Anesthesiology
IS - 1
M1 - 12
ER -